Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Davi

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|January 2, 2023
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identityElectra Sofou, Laura Zaragoza-Infante, Nikolaos Pechlivanis, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Identification of prognostic factors in post-transplant lymphoproliferative disordersSylvain Choquet, Bruneel Marie-France Mamzer, Olivier Hermine, et al.
Leukemia|June 30, 2023
Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working GroupElectra Sofou, Elisavet Vlachonikola, Laura Zaragoza-Infante, et al.
Annals of Hematology|April 3, 2009
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamideKarim Maloum, Catherine Settegrana, Elise Chapiro, et al.
Molecular Medicine (Cambridge, Mass.)|October 5, 2011
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypyEugenia Tsakou, Andreas Agathangelidis, Andreas Agathagelidis, et al.
Leukemia|September 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemiaLudovic Jondreville, Lea Dehgane, Cecile Doualle, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Hemasphere|November 15, 2019
A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality ConsortiumMarine Armand, Coralie Derrieux, Kheira Beldjord, et al.
American Journal of Hematology|October 30, 2013
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic dataPanagiotis Baliakas, Michalis Iskas, Anne Gardiner, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|January 2, 2023
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identityElectra Sofou, Laura Zaragoza-Infante, Nikolaos Pechlivanis, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Identification of prognostic factors in post-transplant lymphoproliferative disordersSylvain Choquet, Bruneel Marie-France Mamzer, Olivier Hermine, et al.
Leukemia|June 30, 2023
Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working GroupElectra Sofou, Elisavet Vlachonikola, Laura Zaragoza-Infante, et al.
Annals of Hematology|April 3, 2009
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamideKarim Maloum, Catherine Settegrana, Elise Chapiro, et al.
Molecular Medicine (Cambridge, Mass.)|October 5, 2011
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypyEugenia Tsakou, Andreas Agathangelidis, Andreas Agathagelidis, et al.
Leukemia|September 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemiaLudovic Jondreville, Lea Dehgane, Cecile Doualle, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Hemasphere|November 15, 2019
A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality ConsortiumMarine Armand, Coralie Derrieux, Kheira Beldjord, et al.
American Journal of Hematology|October 30, 2013
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic dataPanagiotis Baliakas, Michalis Iskas, Anne Gardiner, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Pageof 7